SI
RMD icon

Sensato Investors’s ResMed RMD Stock Holding History

Sensato Investors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-66,800
Closed -$9.84M – 16
2020
Q1 		$9.84M Buy
66,800
+63,600
+1,988% +$10.1M 8.06% 3
2019
Q4 		$496K Hold
3,200
– – 0.34% 23
2019
Q3 		$432K Buy
+3,200
New +$419K 0.16% 51
2016
Q2 		– Sell
-24,300
Closed -$1.41M – 112
2016
Q1 		$1.41M Buy
+24,300
New +$1.38M 0.25% 65

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sensato Investors's RMD Position: Q2 2020 in Review

Sensato Investors sold out of ResMed (RMD) in Q2 2020, closing a stake of 66,800 shares — an estimated $9.84M sold.

Sensato Investors first reported a position in RMD in Q1 2016 and held it in 4 quarters. The position peaked at $9.84M in Q1 2020. 583 funds tracked by Wall St. Rank hold RMD as of Q2 2020.

  • Sensato Investors reported no remaining ResMed position as of Q2 2020 after selling out during the quarter.
  • Sensato Investors sold 66,800 ResMed shares in Q2 2020, an estimated $9.84M.
  • Sensato Investors first reported a position in ResMed in Q1 2016 and held it in 4 quarters.
  • Sensato Investors's ResMed position peaked at $9.84M in Q1 2020.
  • 583 funds tracked by Wall St. Rank held ResMed as of Q2 2020.

Based on Sensato Investors's 13F filing for Q2 2020.